Hypertension Research Today is a free monthly online journal that collates and summarizes the latest research about Hypertension, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 4 (2007), Issue 4 (April)

1. Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation.
   Heart, 93(4): 495-9. [Abstract] [Full-text]
2. The relationship between aortic stiffness and cardiac function in patients with obstructive sleep apnea, independently from systemic hypertension.
   J Am Soc Echocardiogr, 20(4): 366-72. [Abstract] [Full-text]
3. Renal artery stenting slows the rate of renal function decline.
   J Vasc Surg, 45(4): 726-31; discussion 731-2. [Abstract] [Full-text]
4. Systemic hypertension.
   Curr Probl Cardiol, 32(4): 201-59. [Abstract] [Full-text]
5. Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats.
   Br J Pharmacol, 150(7): 851-61. [Abstract] [Full-text]
6. Relationship between left ventricle geometric patterns and lymphocyte DNA damage in patients with untreated essential hypertension.
   Clin Biochem, 40(7): 454-9. [Abstract] [Full-text]
7. Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997-2003.
   Pharmacoepidemiol Drug Saf, 16(4): 412-21. [Abstract] [Full-text]
8. The effect of the postnatal environment on altered fetal programming of adult vascular function in mice that lack endothelial nitric oxide synthase.
   Am J Obstet Gynecol, 196(4): 354.e1-7. [Abstract] [Full-text]
9. Hypertensive disorders of pregnancy and the small for gestational age neonate: not a simple relationship.
   Am J Obstet Gynecol, 196(4): 335.e1-5. [Abstract] [Full-text]
10. Variability in response to antihypertensive drugs.
    Am J Med, 120(4): S10-20. [Abstract] [Full-text]
11. An examination of the intentional and unintentional aspects of medication non-adherence in patients diagnosed with hypertension.
    J Clin Nurs, 16(4): 698-706. [Abstract] [Full-text]
12. Self-care agency and factors related to this agency among patients with hypertension.
    J Clin Nurs, 16(4): 679-87. [Abstract] [Full-text]
13. Clinical practice and recent recommendations in hypertension management--reporting a gap in a global survey of 1259 primary care physicians in 17 countries.
    Curr Med Res Opin, 23(4): 783-91. [Abstract] [Full-text]
14. Exercise training-induced remodeling of paraventricular nucleus (nor)adrenergic innervation in normotensive and hypertensive rats.
    Am J Physiol Regul Integr Comp Physiol, 292(4): R1717-27. [Abstract] [Full-text]
15. HO-1 induction lowers blood pressure and superoxide production in the renal medulla of angiotensin II hypertensive mice.
    Am J Physiol Regul Integr Comp Physiol, 292(4): R1472-8. [Abstract] [Full-text]
16. Common variation in KLKB1 and essential hypertension risk: tagging-SNP haplotype analysis in a case-control study.
    Hum Genet, 121(3): 327-35. [Abstract] [Full-text]
17. Effects of acute and chronic L-arginine treatment in experimental hyperuricemia.
    Am J Physiol Renal Physiol, 292(4): F1238-44. [Abstract] [Full-text]
18. Antihypertensive therapy, the alpha-adducin polymorphism, and cardiovascular disease in high-risk hypertensive persons: the Genetics of Hypertension-Associated Treatment Study.
    Pharmacogenomics J, 7(2): 112-22. [Abstract] [Full-text]
19. Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure.
    J Hypertens, 25(5): 1095-9. [Abstract] [Full-text]
20. Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis.
    J Hypertens, 25(5): 1087-94. [Abstract] [Full-text]
21. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    J Hypertens, 25(5): 1079-85. [Abstract] [Full-text]
22. Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities.
    J Hypertens, 25(5): 1073-8. [Abstract] [Full-text]
23. Enhanced angiotensin II production by renal mesangium is responsible for apoptosis/proliferation of endothelial and epithelial cells in a model of malignant hypertension.
    J Hypertens, 25(5): 1041-52. [Abstract] [Full-text]
24. Small artery structure is an independent predictor of cardiovascular events in essential hypertension.
    J Hypertens, 25(5): 1021-6. [Abstract] [Full-text]
25. Hypertension and hypothyroidism: results from an ambulatory blood pressure monitoring study.
    J Hypertens, 25(5): 993-9. [Abstract] [Full-text]
26. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain.
    J Hypertens, 25(5): 977-84. [Abstract] [Full-text]
27. Alcohol consumption and blood pressure in the adult US population: assessment of gender-related effects.
    J Hypertens, 25(5): 965-70. [Abstract] [Full-text]
28. Does self-reported history of hypertension predict cardiovascular death? Comparison with blood pressure measurement in a 19-year prospective study.
    J Hypertens, 25(5): 959-64. [Abstract] [Full-text]
29. Pseudocoarctation as cause of a refractory hypertension.
    J Cardiovasc Med (Hagerstown), 8(4): 289-90. [Abstract] [Full-text]
30. Reproducibility of white-coat and masked hypertension in ambulatory BP monitoring.
    Int J Cardiol, 117(3): 355-9. [Abstract] [Full-text]
31. Blood pressure at rest, during 24 h monitoring and in response to sympathetic stimulation in hypertensive patients with metabolic syndrome.
    Int J Cardiol, 117(3): 312-6. [Abstract] [Full-text]
32. Prevalence of dyslipidemia and associated factors among the hypertensive rural chinese population.
    Arch Med Res, 38(4): 432-9. [Abstract] [Full-text]
33. Essential hypertension and chronic viral hepatitis.
    Dig Liver Dis, 39(5): 466-72. [Abstract] [Full-text]
34. Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients.
    Nitric Oxide, 16(3): 348-55. [Abstract] [Full-text]
35. Cyclic guanosine monophosphate phosphodiesterase-5 inhibitor promotes an endothelium NO-dependent-like vasodilation in patients with refractory hypertension.
    Nitric Oxide, 16(3): 315-21. [Abstract] [Full-text]
36. Antihypertensive medications and risk of diabetes mellitus.
    Curr Opin Nephrol Hypertens, 16(3): 256-60. [Abstract] [Full-text]
37. Treatment options for prehypertension.
    Curr Opin Nephrol Hypertens, 16(3): 250-5. [Abstract] [Full-text]
38. Nocturnal blood pressure changes in patients with restless legs syndrome.
    Neurology, 68(15): 1213-8. [Abstract] [Full-text]
39. Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-CSF-deficient mice.
    Am J Physiol Heart Circ Physiol, 292(4): H1789-95. [Abstract] [Full-text]
40. Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice.
    Am J Physiol Heart Circ Physiol, 292(4): H1770-6. [Abstract] [Full-text]
41. Preeclampsia, pregnancy-related hypertension, and breast cancer risk.
    Am J Epidemiol, 165(9): 1007-14. [Abstract] [Full-text]
42. Deep brain stimulation: a new treatment for hypertension?
    J Clin Neurosci, 14(6): 592-5. [Abstract] [Full-text]
43. Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure.
    Circ Res, 100(7): 1089-98. [Abstract] [Full-text]
44. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore.
    Prev Med, 44(4): 335-40. [Abstract] [Full-text]
45. Genetic dissection of a blood pressure quantitative trait locus on rat chromosome 1 and gene expression analysis identifies SPON1 as a novel candidate hypertension gene.
    Circ Res, 100(7): 992-9. [Abstract] [Full-text]
46. The joint impact of cardiovascular risk factors upon medical costs.
    Prev Med, 44(4): 349-55. [Abstract] [Full-text]
47. Increased risk of pregnancy-induced hypertension in young recipients of donated oocytes.
    Fertil Steril, 87(4): 776-81. [Abstract] [Full-text]
48. Psychomotor speed in hypertension: effects of reaction time components, stimulus modality, and phase of the cardiac cycle.
    Psychophysiology, 44(3): 459-68. [Abstract] [Full-text]
49. Microlevel determinants of blood pressure among women of two ethnic groups in a periurban area of Kolkata city, India.
    Am J Hum Biol, 19(3): 409-15. [Abstract] [Full-text]
50. Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan.
    Pharmacol Res, 55(5): 408-17. [Abstract] [Full-text]
51. Modulation of vascular reactivity in normal, hypertensive and diabetic rat aortae by a non-antioxidant flavonoid.
    Pharmacol Res, 55(5): 385-91. [Abstract] [Full-text]
52. Erythrocyte morphology automated analysis: proposal for a new prediction tool of essential hypertension diagnosis.
    Cytometry B Clin Cytom, 72(3): 211-4. [Abstract] [Full-text]
53. Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study.
    Circulation, 115(15): 1991-8. [Abstract] [Full-text]
54. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota.
    Circulation, 115(15): 1982-90. [Abstract] [Full-text]
55. Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension.
    Circulation, 115(15): 1999-2005. [Abstract] [Full-text]
56. The 5-hydroxytryptamine2A receptor is involved in (+)-norfenfluramine-induced arterial contraction and blood pressure increase in deoxycorticosterone acetate-salt hypertension.
    J Pharmacol Exp Ther, 321(2): 485-91. [Abstract] [Full-text]
57. The in vitro and in vivo cardiovascular effects of Delta9-tetrahydrocannabinol in rats made hypertensive by chronic inhibition of nitric-oxide synthase.
    J Pharmacol Exp Ther, 321(2): 663-72. [Abstract] [Full-text]
58. Role of nitric oxide in alpha-melanocyte-stimulating hormone-induced hypotension in the nucleus tractus solitarii of the spontaneously hypertensive rats.
    J Pharmacol Exp Ther, 321(2): 455-61. [Abstract] [Full-text]
59. Blood pressure and risks of vascular complications after percutaneous coronary intervention.
    Dimens Crit Care Nurs, 26(3): 121-7. [Abstract] [Full-text]
60. Melatonin as a potential antihypertensive treatment.
    J Pineal Res, 42(4): 319-22. [Abstract] [Full-text]
61. Mercury intoxication in a 2-year-old girl: a diagnostic challenge for the physician.
    Pediatr Nephrol, 22(6): 903-6. [Abstract] [Full-text]
62. MRI changes in thrombotic microangiopathy secondary to malignant hypertension.
    J Neuroimaging, 17(2): 178-80. [Abstract] [Full-text]
63. Barbershops as hypertension detection, referral, and follow-up centers for black men.
    Hypertension, 49(5): 1040-6. [Abstract] [Full-text]
64. Previous hypertensive disease of pregnancy is associated with alterations of markers of insulin resistance.
    Hypertension, 49(5): 1056-62. [Abstract] [Full-text]
65. Ambulatory arterial stiffness index is not a specific marker of reduced arterial compliance.
    Hypertension, 49(5): 986-91. [Abstract] [Full-text]
66. Voltage-dependent calcium currents are enhanced in nucleus of the solitary tract neurons isolated from renal wrap hypertensive rats.
    Hypertension, 49(5): 1163-9. [Abstract] [Full-text]
67. CYP3A5 and ABCB1 genes influence blood pressure and response to treatment, and their effect is modified by salt.
    Hypertension, 49(5): 1007-14. [Abstract] [Full-text]
68. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension.
    Hypertension, 49(5): 1063-9. [Abstract] [Full-text]
69. Inappropriate left ventricular mass changes during treatment adversely affects cardiovascular prognosis in hypertensive patients.
    Hypertension, 49(5): 1077-83. [Abstract] [Full-text]
70. Impact of smoking and smoking cessation on arterial stiffness and aortic wave reflection in hypertension.
    Hypertension, 49(5): 981-5. [Abstract] [Full-text]
71. Direct Renin inhibition with aliskiren in obese patients with arterial hypertension.
    Hypertension, 49(5): 1047-55. [Abstract] [Full-text]
72. Cerebral hemodynamics after short- and long-term reduction in blood pressure in mild and moderate hypertension.
    Hypertension, 49(5): 1149-55. [Abstract] [Full-text]
73. Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload.
    Hypertension, 49(5): 1084-94. [Abstract] [Full-text]
74. Retrospective analysis of coagulation factor II receptor (F2R) sequence variation and coronary heart disease in hypertensive patients.
    Arterioscler Thromb Vasc Biol, 27(5): 1213-9. [Abstract] [Full-text]
75. Genetic variations associated with echocardiographic left ventricular traits in hypertensive blacks.
    Hypertension, 49(5): 992-9. [Abstract] [Full-text]
76. Disturbed diurnal rhythm alters gene expression and exacerbates cardiovascular disease with rescue by resynchronization.
    Hypertension, 49(5): 1104-13. [Abstract] [Full-text]
77. Fos-related antigen immunoreactivity after acute and chronic angiotensin II-induced hypertension in the rabbit brain.
    Hypertension, 49(5): 1170-7. [Abstract] [Full-text]
78. Molecular genetics of experimental hypertension and the metabolic syndrome: from gene pathways to new therapies.
    Hypertension, 49(5): 941-52. [Abstract] [Full-text]
79. Activity and regulation of Na+-HCO3- cotransporter in immortalized spontaneously hypertensive rat and Wistar-Kyoto rat proximal tubular epithelial cells.
    Hypertension, 49(5): 1186-93. [Abstract] [Full-text]
80. Obesity and benign prostatic enlargement: a large observational study in China.
    Urology, 69(4): 680-4. [Abstract] [Full-text]
81. Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study.
    J Intern Med, 261(5): 472-9. [Abstract] [Full-text]
82. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
    Cardiovasc Diabetol, 6: 12. [Abstract] [Full-text]
83. Synergistic expression of angiotensin-converting enzyme (ACE) and ACE2 in human renal tissue and confounding effects of hypertension on the ACE to ACE2 ratio.
    Endocrinology, 148(5): 2453-7. [Abstract] [Full-text]
84. Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats.
    Microvasc Res, 73(3): 198-205. [Abstract] [Full-text]
85. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG), a reliable oxidative stress marker in hypertension.
    Free Radic Res, 41(5): 546-54. [Abstract] [Full-text]
86. Antihypertensive adherence and drug class among Asian Pacific Americans.
    Ethn Health, 12(3): 265-81. [Abstract] [Full-text]
87. Diastolic filling abnormalities in children with essential hypertension.
    J Pediatr, 150(5): 503-9. [Abstract] [Full-text]
88. Longitudinal relationship of parental hypertension with body mass index, blood pressure, and cardiovascular reactivity in children.
    J Pediatr, 150(5): 498-502. [Abstract] [Full-text]
89. White coat hypertension in childhood: evidence for end-organ effect.
    J Pediatr, 150(5): 491-7. [Abstract] [Full-text]
90. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk.
    Circulation, 115(16): 2145-52. [Abstract] [Full-text]
91. Thymoquinone supplementation attenuates hypertension and renal damage in nitric oxide deficient hypertensive rats.
    Phytother Res, 21(5): 410-4. [Abstract] [Full-text]
92. Elevated platelet P-selectin expression and platelet activation in high risk patients with uncontrolled severe hypertension.
    Atherosclerosis, 192(1): 148-54. [Abstract] [Full-text]
93. The association between pre-hypertension status and oxidative stress markers related to atherosclerotic disease: the ATTICA study.
    Atherosclerosis, 192(1): 169-76. [Abstract] [Full-text]
94. Fetal development: voice processing in normotensive and hypertensive pregnancies.
    Biol Res Nurs, 8(4): 272-82. [Abstract] [Full-text]
95. A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension.
    Pediatr Nephrol, 22(5): 695-701. [Abstract] [Full-text]
96. Coerulear activation by crh and its role in hypertension induced by prenatal malnutrition in the rat.
    Int J Neurosci, 117(5): 627-42. [Abstract] [Full-text]
97. A reduction in alcohol consumption is associated with reduced plasma F2-isoprostanes and urinary 20-HETE excretion in men.
    Free Radic Biol Med, 42(11): 1730-5. [Abstract] [Full-text]
98. Severe hypertension in the geriatric patient-is it an emergency or not?
    Clin Geriatr Med, 23(2): 363-70, vii. [Abstract] [Full-text]
99. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP).
    BMJ, 334(7599): 885. [Abstract] [Full-text]
100. High pressure promotes monocyte adhesion to the vascular wall.
     Circ Res, 100(8): 1226-33. [Abstract] [Full-text]
101. Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study.
     Lancet, 369(9571): 1431-9. [Abstract] [Full-text]
102. Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients.
     Diabetes Care, 30(5): 1255-60. [Abstract] [Full-text]
103. Knocking down the diencephalic thyrotropin-releasing hormone precursor gene normalizes obesity-induced hypertension in the rat.
     Am J Physiol Endocrinol Metab, 292(5): E1388-94. [Abstract] [Full-text]
104. African-American and Hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: results from LUMINA, a multiethnic cohort (LUMINAXLV).
     Ann Rheum Dis, 66(5): 618-22. [Abstract] [Full-text]

© 2004-2008 Hypertension Research Today. All Rights Reserved.